| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RasGAP_dom | 6.58e-05 | 18 | 83 | 3 | IPR001936 | |
| Domain | PSI | 3.82e-04 | 32 | 83 | 3 | PF01437 | |
| Domain | Plexin_repeat | 3.82e-04 | 32 | 83 | 3 | IPR002165 | |
| Domain | LAM_G_DOMAIN | 6.38e-04 | 38 | 83 | 3 | PS50025 | |
| Domain | Plexin_cytopl | 6.88e-04 | 9 | 83 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 6.88e-04 | 9 | 83 | 2 | IPR013548 | |
| Domain | Plexin | 6.88e-04 | 9 | 83 | 2 | IPR031148 | |
| Domain | Laminin_G_2 | 7.43e-04 | 40 | 83 | 3 | PF02210 | |
| Domain | DAGK_acc | 8.58e-04 | 10 | 83 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 8.58e-04 | 10 | 83 | 2 | IPR000756 | |
| Domain | DAGKa | 8.58e-04 | 10 | 83 | 2 | SM00045 | |
| Domain | PSI | 9.83e-04 | 44 | 83 | 3 | IPR016201 | |
| Domain | LamG | 9.83e-04 | 44 | 83 | 3 | SM00282 | |
| Domain | PSI | 1.12e-03 | 46 | 83 | 3 | SM00423 | |
| Domain | CUB | 1.69e-03 | 53 | 83 | 3 | PS01180 | |
| Domain | DAGKc | 1.72e-03 | 14 | 83 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.97e-03 | 15 | 83 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.97e-03 | 15 | 83 | 2 | PF00781 | |
| Domain | DAGK | 1.97e-03 | 15 | 83 | 2 | PS50146 | |
| Domain | CUB_dom | 2.08e-03 | 57 | 83 | 3 | IPR000859 | |
| Domain | Laminin_G | 2.19e-03 | 58 | 83 | 3 | IPR001791 | |
| Domain | - | 2.25e-03 | 16 | 83 | 2 | 1.10.506.10 | |
| Domain | NAD/diacylglycerol_kinase | 2.54e-03 | 17 | 83 | 2 | IPR016064 | |
| Domain | PDZ | 3.61e-03 | 141 | 83 | 4 | PF00595 | |
| Domain | - | 3.67e-03 | 333 | 83 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.78e-03 | 335 | 83 | 6 | IPR015943 | |
| Domain | FA58C | 3.88e-03 | 21 | 83 | 2 | SM00231 | |
| Domain | FA58C_3 | 3.88e-03 | 21 | 83 | 2 | PS50022 | |
| Domain | FA58C_1 | 3.88e-03 | 21 | 83 | 2 | PS01285 | |
| Domain | FA58C_2 | 3.88e-03 | 21 | 83 | 2 | PS01286 | |
| Domain | PDZ | 4.29e-03 | 148 | 83 | 4 | SM00228 | |
| Domain | - | 4.49e-03 | 150 | 83 | 4 | 2.30.42.10 | |
| Domain | PDZ | 4.60e-03 | 151 | 83 | 4 | PS50106 | |
| Domain | PDZ | 4.71e-03 | 152 | 83 | 4 | IPR001478 | |
| Domain | F5_F8_type_C | 5.05e-03 | 24 | 83 | 2 | PF00754 | |
| Domain | FA58C | 5.05e-03 | 24 | 83 | 2 | IPR000421 | |
| Domain | IPT | 6.37e-03 | 27 | 83 | 2 | SM00429 | |
| Domain | Rho_GTPase_activation_prot | 7.08e-03 | 88 | 83 | 3 | IPR008936 | |
| Domain | EGF_LAM_2 | 7.83e-03 | 30 | 83 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 7.83e-03 | 30 | 83 | 2 | PS01248 | |
| Domain | - | 7.90e-03 | 391 | 83 | 6 | 2.30.29.30 | |
| Domain | PH | 7.97e-03 | 278 | 83 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 8.08e-03 | 279 | 83 | 5 | PS50003 | |
| Domain | PH_domain | 8.20e-03 | 280 | 83 | 5 | IPR001849 | |
| Domain | TIG | 8.35e-03 | 31 | 83 | 2 | PF01833 | |
| Domain | Sema | 8.35e-03 | 31 | 83 | 2 | SM00630 | |
| Domain | Semap_dom | 8.35e-03 | 31 | 83 | 2 | IPR001627 | |
| Domain | Sema | 8.35e-03 | 31 | 83 | 2 | PF01403 | |
| Domain | SEMA | 8.35e-03 | 31 | 83 | 2 | PS51004 | |
| Domain | Galactose-bd-like | 8.48e-03 | 94 | 83 | 3 | IPR008979 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PPP1R26 RADIL SHROOM3 THADA PER2 ZNF296 MEGF8 ZNRF3 ZFP36L2 PPA2 STRN4 POLRMT LRP3 IRS2 ULK1 LTK BRAT1 PLXNB2 HECTD1 ZNF865 BIRC6 KIAA2013 ARHGEF10L ZNF503 | 5.23e-16 | 1105 | 90 | 24 | 35748872 |
| Pubmed | PPP1R26 RADIL THADA TBC1D30 RTEL1 TBC1D12 HECTD1 BIRC6 CCDC85A KIAA2013 | 6.21e-07 | 493 | 90 | 10 | 15368895 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 9.48e-07 | 29 | 90 | 4 | 31491374 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 31150793 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20610402 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30985063 | ||
| Pubmed | Functional regulation of semaphorin receptors by proprotein convertases. | 6.62e-06 | 2 | 90 | 2 | 12533544 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26807827 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 35348702 | ||
| Pubmed | BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein. | 1.49e-05 | 57 | 90 | 4 | 27433848 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26035216 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26275342 | ||
| Pubmed | Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. | 1.98e-05 | 3 | 90 | 2 | 15330859 | |
| Pubmed | Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis. | 1.98e-05 | 3 | 90 | 2 | 29920840 | |
| Pubmed | PCAF Involvement in Lamin A/C-HDAC2 Interplay during the Early Phase of Muscle Differentiation. | 1.98e-05 | 3 | 90 | 2 | 32698523 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 18694874 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 15147296 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9013772 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 22505611 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 33909026 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 29981480 | ||
| Pubmed | 4.69e-05 | 27 | 90 | 3 | 27144312 | ||
| Pubmed | The floor plate is sufficient for development of the sclerotome and spine without the notochord. | 6.59e-05 | 5 | 90 | 2 | 21111815 | |
| Pubmed | Order of six loci at 2q24-q31 and orientation of the HOXD locus. | 6.59e-05 | 5 | 90 | 2 | 7896287 | |
| Pubmed | Structure and function of the intracellular region of the plexin-b1 transmembrane receptor. | 6.59e-05 | 5 | 90 | 2 | 19843518 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 9286595 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 12183458 | ||
| Pubmed | Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins. | 6.59e-05 | 5 | 90 | 2 | 29040270 | |
| Pubmed | Interplay between scatter factor receptors and B plexins controls invasive growth. | 6.59e-05 | 5 | 90 | 2 | 15184888 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 18799546 | ||
| Pubmed | Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum. | 7.87e-05 | 32 | 90 | 3 | 35156680 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 8.58e-05 | 544 | 90 | 8 | 28473536 | |
| Pubmed | 8.98e-05 | 173 | 90 | 5 | 23979707 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 1611218 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 7743923 | ||
| Pubmed | Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo. | 9.87e-05 | 6 | 90 | 2 | 8084603 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 9.87e-05 | 6 | 90 | 2 | 34143959 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 17359303 | ||
| Pubmed | Pax1 and Pax9 synergistically regulate vertebral column development. | 9.87e-05 | 6 | 90 | 2 | 10556064 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 23439647 | ||
| Pubmed | Duplications of hox gene clusters and the emergence of vertebrates. | 9.87e-05 | 6 | 90 | 2 | 23501471 | |
| Pubmed | Emx1 and Emx2 functions in development of dorsal telencephalon. | 1.38e-04 | 7 | 90 | 2 | 9006071 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 21151128 | ||
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 11747084 | ||
| Pubmed | Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons. | 1.54e-04 | 40 | 90 | 3 | 26671461 | |
| Pubmed | 1.63e-04 | 446 | 90 | 7 | 24255178 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | LPCAT1 THADA PDE12 ZNRF3 NDFIP2 ZNF598 BRAT1 PLXNB2 HECTD1 KIAA2013 | 1.64e-04 | 942 | 90 | 10 | 31073040 |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 15661641 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 8812145 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 10804169 | ||
| Pubmed | Uncx4.1 is required for the formation of the pedicles and proximal ribs and acts upstream of Pax9. | 1.84e-04 | 8 | 90 | 2 | 10804168 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 19956724 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.32e-04 | 212 | 90 | 5 | 33853758 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 2.33e-04 | 333 | 90 | 6 | 32665550 | |
| Pubmed | Impaired intervertebral disc formation in the absence of Jun. | 2.36e-04 | 9 | 90 | 2 | 12441295 | |
| Pubmed | Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. | 2.36e-04 | 9 | 90 | 2 | 15568017 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 35618666 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 25892012 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 12482924 | ||
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 23727513 | ||
| Pubmed | Follistatin interacts with Noggin in the development of the axial skeleton. | 2.94e-04 | 10 | 90 | 2 | 24514266 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 12730235 | ||
| Pubmed | Embryonic expression of cyclooxygenase-2 causes malformations in axial skeleton. | 2.94e-04 | 10 | 90 | 2 | 20236942 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 24951543 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 15878992 | ||
| Pubmed | Mitochondrial retention of Opa1 is required for mouse embryogenesis. | 3.59e-04 | 11 | 90 | 2 | 20652258 | |
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 3.59e-04 | 11 | 90 | 2 | 27766308 | |
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 10589677 | ||
| Pubmed | lunatic fringe is an essential mediator of somite segmentation and patterning. | 3.59e-04 | 11 | 90 | 2 | 9690473 | |
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 17021016 | ||
| Pubmed | Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. | 3.59e-04 | 11 | 90 | 2 | 10196361 | |
| Pubmed | 3.88e-04 | 515 | 90 | 7 | 31617661 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.95e-04 | 861 | 90 | 9 | 36931259 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 36399562 | ||
| Pubmed | Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. | 4.30e-04 | 12 | 90 | 2 | 12123608 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 20478304 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 4.30e-04 | 12 | 90 | 2 | 14645221 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 4.30e-04 | 12 | 90 | 2 | 21270798 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 24475213 | ||
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 17572911 | ||
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 24572910 | ||
| Pubmed | Mechanochemical control of epidermal stem cell divisions by B-plexins. | 5.07e-04 | 13 | 90 | 2 | 33637728 | |
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 26811377 | ||
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 10520995 | ||
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 19805522 | ||
| Pubmed | Plag1 and Plagl2 have overlapping and distinct functions in telencephalic development. | 5.07e-04 | 13 | 90 | 2 | 30361413 | |
| Pubmed | Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. | 5.07e-04 | 13 | 90 | 2 | 9811581 | |
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 21552538 | ||
| Pubmed | 5.07e-04 | 13 | 90 | 2 | 23277359 | ||
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 1354647 | ||
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 22955271 | ||
| Pubmed | Genome-wide association study of pancreatic cancer in Japanese population. | 5.91e-04 | 14 | 90 | 2 | 20686608 | |
| Pubmed | 5.91e-04 | 14 | 90 | 2 | 36213234 | ||
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 5.91e-04 | 14 | 90 | 2 | 10090727 | |
| Pubmed | LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. | 5.91e-04 | 14 | 90 | 2 | 15545629 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 6.80e-04 | 15 | 90 | 2 | 15895400 | |
| Pubmed | Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. | 6.80e-04 | 15 | 90 | 2 | 10051567 | |
| Pubmed | Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development. | 6.80e-04 | 15 | 90 | 2 | 21122816 | |
| Pubmed | Neural defects caused by total and Wnt1-Cre mediated ablation of p120ctn in mice. | 6.80e-04 | 15 | 90 | 2 | 32741376 | |
| Pubmed | 6.80e-04 | 15 | 90 | 2 | 34927678 | ||
| Interaction | TOP3B interactions | PPP1R26 RADIL ANOS1 SHROOM3 THADA PER2 ZNF296 MEGF8 ZNRF3 ZFP36L2 RTEL1 PPA2 STRN4 POLRMT LRP3 IRS2 ULK1 LTK ZNF598 BRAT1 PLXNB2 HECTD1 ZNF865 BIRC6 PRRC2A KIAA2013 ARHGEF10L ZNF503 | 1.14e-11 | 1470 | 88 | 28 | int:TOP3B |
| Cytoband | 9p13.1 | 1.02e-03 | 24 | 90 | 2 | 9p13.1 | |
| Cytoband | 3p22.3 | 1.70e-03 | 31 | 90 | 2 | 3p22.3 | |
| Cytoband | 7p22.3 | 2.05e-03 | 34 | 90 | 2 | 7p22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 2.37e-03 | 134 | 90 | 3 | chr7p22 | |
| Cytoband | 22q13.33 | 2.55e-03 | 38 | 90 | 2 | 22q13.33 | |
| Cytoband | 10q22.2 | 2.97e-03 | 41 | 90 | 2 | 10q22.2 | |
| GeneFamily | Plexins | 3.71e-04 | 9 | 59 | 2 | 683 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 4.63e-04 | 10 | 59 | 2 | 1178 | |
| GeneFamily | PDZ domain containing | 1.53e-03 | 152 | 59 | 4 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.20e-03 | 718 | 59 | 8 | 28 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.27e-06 | 350 | 86 | 9 | M1949 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.67e-06 | 357 | 86 | 9 | MM828 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ESPN ANOS1 WNT1 ZAR1 LAMA3 DGKI DLX1 PAX1 LTK CDK5R2 PTPRT EDN3 ZNF503 | 3.16e-05 | 1035 | 86 | 13 | M9898 |
| Coexpression | ESC_J1_UP_LATE.V1_UP | 3.46e-05 | 186 | 86 | 6 | M2768 | |
| Coexpression | BENPORATH_EED_TARGETS | ESPN ANOS1 FOXQ1 DSP WNT1 DGKI DLX1 PAX1 LTK NRN1 CDK5R2 PTPRT ZNF503 | 4.01e-05 | 1059 | 86 | 13 | M7617 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.09e-06 | 108 | 86 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.34e-06 | 120 | 86 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 9.38e-06 | 33 | 86 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_500 | 3.92e-05 | 47 | 86 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_200 | 5.85e-05 | 166 | 86 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.78e-05 | 108 | 86 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.01e-05 | 58 | 86 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_200 | 1.07e-04 | 23 | 86 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 1.81e-04 | 204 | 86 | 6 | ratio_EB_vs_SC_500_K3 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.85e-04 | 498 | 86 | 9 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.21e-04 | 73 | 86 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.84e-04 | 416 | 86 | 8 | ratio_EB_vs_SC_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 2.85e-04 | 78 | 86 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-07 | 200 | 89 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-06 | 177 | 89 | 6 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.83e-06 | 183 | 89 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-06 | 186 | 89 | 6 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.08e-06 | 187 | 89 | 6 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 187 | 89 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.21e-06 | 189 | 89 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 191 | 89 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 197 | 89 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 198 | 89 | 6 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 198 | 89 | 6 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 199 | 89 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-06 | 200 | 89 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 89 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 89 | 6 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-06 | 200 | 89 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Ionocyte-iono-4|World / Class top | 6.13e-06 | 129 | 89 | 5 | 85ee6e16959cb58a58f5b09edf1f78d9ce6a9441 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.20e-05 | 148 | 89 | 5 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.20e-05 | 148 | 89 | 5 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 168 | 89 | 5 | 3e3f611e9bbec8224264666be14a4e7db343070e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-05 | 179 | 89 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.99e-05 | 179 | 89 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-05 | 179 | 89 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 181 | 89 | 5 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-05 | 181 | 89 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 181 | 89 | 5 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.32e-05 | 183 | 89 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 183 | 89 | 5 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 183 | 89 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.40e-05 | 184 | 89 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-05 | 184 | 89 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.40e-05 | 184 | 89 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-05 | 185 | 89 | 5 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.59e-05 | 186 | 89 | 5 | 3314def702fe6a5056d0dadbb3a587c5d1a16412 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 89 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 3.59e-05 | 186 | 89 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 89 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.59e-05 | 186 | 89 | 5 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.68e-05 | 187 | 89 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.77e-05 | 188 | 89 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-05 | 188 | 89 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.77e-05 | 188 | 89 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.77e-05 | 188 | 89 | 5 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 3.87e-05 | 189 | 89 | 5 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.07e-05 | 191 | 89 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 192 | 89 | 5 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.17e-05 | 192 | 89 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 193 | 89 | 5 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 193 | 89 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 193 | 89 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 193 | 89 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-05 | 193 | 89 | 5 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.38e-05 | 194 | 89 | 5 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 195 | 89 | 5 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 195 | 89 | 5 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-05 | 195 | 89 | 5 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-05 | 195 | 89 | 5 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.60e-05 | 196 | 89 | 5 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.60e-05 | 196 | 89 | 5 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 4.60e-05 | 196 | 89 | 5 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 197 | 89 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.71e-05 | 197 | 89 | 5 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.71e-05 | 197 | 89 | 5 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.71e-05 | 197 | 89 | 5 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.71e-05 | 197 | 89 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.71e-05 | 197 | 89 | 5 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.71e-05 | 197 | 89 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.71e-05 | 197 | 89 | 5 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 4.71e-05 | 197 | 89 | 5 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-05 | 198 | 89 | 5 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 50852713c017217c79777c95857097103bcf2fbe | |
| ToppCell | 15-Distal-Epithelial-Bud_tip_adjacent|Distal / Age, Tissue, Lineage and Cell class | 4.83e-05 | 198 | 89 | 5 | f4d9d5995a42f71bf412f0ad299fc963bad3a898 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.83e-05 | 198 | 89 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.83e-05 | 198 | 89 | 5 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.83e-05 | 198 | 89 | 5 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 4.83e-05 | 198 | 89 | 5 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-05 | 199 | 89 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.06e-05 | 200 | 89 | 5 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.06e-05 | 200 | 89 | 5 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.06e-05 | 200 | 89 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.06e-05 | 200 | 89 | 5 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-05 | 200 | 89 | 5 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.06e-05 | 200 | 89 | 5 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.06e-05 | 200 | 89 | 5 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 129 | 89 | 4 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.21e-04 | 148 | 89 | 4 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.27e-04 | 149 | 89 | 4 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| Disease | glomerulonephritis | 2.40e-05 | 3 | 84 | 2 | MONDO_0002462 | |
| Disease | nevus count, cutaneous melanoma | 1.35e-04 | 91 | 84 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.22e-04 | 8 | 84 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Sudden Cardiac Arrest | 2.22e-04 | 8 | 84 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 2.22e-04 | 8 | 84 | 2 | C0085298 | |
| Disease | creatinine measurement, glomerular filtration rate | 3.55e-04 | 117 | 84 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | urea measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0011005 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 3.55e-04 | 10 | 84 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Hamman-Rich syndrome | 7.13e-04 | 14 | 84 | 2 | C0085786 | |
| Disease | urolithiasis | 7.81e-04 | 63 | 84 | 3 | MONDO_0024647 | |
| Disease | 4-acetamidobutanoate measurement | 9.36e-04 | 16 | 84 | 2 | EFO_0021003 | |
| Disease | Usual Interstitial Pneumonia | 1.33e-03 | 19 | 84 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 1.33e-03 | 19 | 84 | 2 | C4721508 | |
| Disease | renal system measurement | 1.47e-03 | 20 | 84 | 2 | EFO_0004742 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 1.47e-03 | 20 | 84 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 1.62e-03 | 21 | 84 | 2 | C1800706 | |
| Disease | creatinine measurement | 2.08e-03 | 995 | 84 | 9 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAAPRSDACLLGSGS | 101 | O60347 | |
| SGADSTACSRAGTPG | 36 | Q8N715 | |
| CAARPSAGVGGSSSS | 91 | Q8NHY2 | |
| CDGSAAPASSVGGHL | 401 | Q6PJG6 | |
| GSALGSSGRQAPCGE | 1251 | Q9HCE6 | |
| ARCAAGAASGSPARE | 1201 | Q9BZ76 | |
| AAAAAASGPGCSSAA | 31 | Q9NR09 | |
| ASGPGCSSAAGAGAA | 36 | Q9NR09 | |
| AGGGSDFGCSAAAPR | 431 | Q03828 | |
| ATAAGAVCLPAGGAG | 156 | P0DPF6 | |
| GSALANGRALSAGSP | 196 | P56177 | |
| RGSSEAGAGGAVCSP | 1291 | Q9P1Z9 | |
| DGGCPGSARTAAGKS | 171 | Q8N1I8 | |
| RARGCLGAAGPTSSG | 11 | Q8NEG7 | |
| GGAPAASSAARDSCA | 341 | Q13319 | |
| PGAGSSGCRLSSVEA | 1731 | Q9C0F0 | |
| SEPSSCTSAGGAGLA | 811 | Q76LX8 | |
| APLACAAAAGRAGGS | 6 | P0C854 | |
| AEGSGQALASPGSCL | 1591 | P02462 | |
| GGAAAGSSAYPAVCR | 21 | P20936 | |
| LCGAALGARGAASPT | 381 | Q96JH8 | |
| LAASSGCLAAGPGAA | 16 | P23352 | |
| CGPRAAPASSAGASD | 6 | Q8NF37 | |
| CGQPADKASASGSGA | 591 | P02545 | |
| ACGATARDPGAAAGL | 31 | Q16787 | |
| AGGSGACGPATAVAA | 46 | Q92831 | |
| LESAGPGCGQRRSSS | 621 | B1AK53 | |
| FGAAGAILCSSPGSQ | 11 | P29376 | |
| ASTGRLAPAGATAGF | 1086 | Q86YR7 | |
| SLGCDASPSGAGSSD | 1081 | O15055 | |
| AAAGASGASALCAFP | 311 | O43157 | |
| FGTCLAASVAAPGSG | 276 | O15031 | |
| RKSRPNASGGAACSG | 96 | Q6L8Q7 | |
| CVAGSAFSGPRLASA | 46 | O75616 | |
| CASQAAGAAPEGTGL | 91 | Q8WX77 | |
| AVLGSLSPGARAGDC | 16 | Q7Z7M0 | |
| ARGATAGASACQGGL | 51 | Q6ZV70 | |
| GRLSSAVPALAACSG | 31 | O75074 | |
| CGSGNGAAGSLLPAF | 111 | Q9NPD7 | |
| NGGSACSSRSDLPGS | 266 | Q15599 | |
| AGGALGPTSGASCRL | 106 | Q2VPB7 | |
| GGGASARSSRPSCAN | 266 | Q96S07 | |
| CPGLRAGLAASIAGS | 721 | Q86XP1 | |
| AALSRSASVRCAGPG | 326 | Q7Z6J2 | |
| PGARAQSAAGGCSFD | 21 | O14522 | |
| ASCSASLPGALGGSA | 161 | Q9Y4H2 | |
| MTPGAALAGSGSGSC | 656 | Q9Y4H2 | |
| CRNGGGRGPAATTSS | 56 | Q9NV92 | |
| AAAAGPGAGGSALRC | 21 | P15863 | |
| AAAGGTVSGPSSACK | 241 | Q9ULT8 | |
| PSSAVGCGAGTDANR | 466 | Q9BYI3 | |
| AAGFVPCSQSGDAGR | 16 | P14138 | |
| PCSGAACAPSAAAGA | 36 | O75912 | |
| FLRGAGSIAGASASP | 2011 | P15924 | |
| AAAAAAATSGSGGCP | 61 | Q5VZB9 | |
| GGAAAAAAAAESCSP | 6 | Q96PX6 | |
| GSLPAAGLSGLCART | 106 | P0C7T7 | |
| AAAASPCRAAAGGQG | 121 | Q9GZT9 | |
| PCRAAAGGQGSAVAA | 126 | Q9GZT9 | |
| TAGGVCGPRRSSSAS | 31 | O00411 | |
| ARCAAGAASGSPARE | 1201 | Q96NU0 | |
| CAANSPAAGGGARDT | 46 | Q9C009 | |
| SARSGLSGLGSCLPG | 51 | O76013 | |
| GFFSLARGGCPSLST | 631 | Q9BVN2 | |
| APGSTGATFLAVCRG | 611 | Q9NZ71 | |
| GLGASPSSCGFQVAR | 941 | Q9H987 | |
| SFPSLGSCNSRGALG | 581 | Q6YHU6 | |
| CSQRSSPDGGLKGAA | 1666 | P48634 | |
| APSTEAGGGLTCASA | 96 | O15446 | |
| AGPGSRSLSCSERGQ | 1271 | Q8TF72 | |
| PSCATAGTEAGGARG | 981 | Q5T8A7 | |
| GAPAAACLRLGTSAG | 11 | Q9H2U2 | |
| SAGSSPSCSLAGRGV | 26 | Q9BXB5 | |
| ALVSDSFSCGGSPGS | 81 | Q8IXZ3 | |
| TCSSGSALGPGAGAA | 11 | Q96FZ5 | |
| PAAASGGTSICSGLR | 376 | A8K7I4 | |
| AGGGASSGPERFSCA | 781 | P0CJ78 | |
| GEPCAQSLGRGAAAS | 246 | Q96SZ4 | |
| GRSLDANSGGCSPEA | 476 | Q8N7X1 | |
| SALAGRRGDASCPSS | 71 | Q6ZSV7 | |
| GLGAAEAFPSGCTAT | 766 | Q9Y2I9 | |
| AASGAGAAALRPFAC | 341 | Q5TEC3 | |
| AAAAAAPERGGGSCV | 16 | Q86UK7 | |
| AAAAGSLGCSKPAGS | 396 | Q96F45 | |
| GTAGTAGRACNSSSP | 306 | P04628 | |
| SRSPCRASEAGGSGS | 601 | Q9ULT6 | |
| AAAASSCRPLGSGAG | 11 | Q9NRL3 | |
| AANGSSCGSAAAGGP | 81 | P47974 | |
| PAELDSGACGGSSLN | 61 | Q96BW1 | |
| GRAGPFSSSRCGASV | 416 | O75385 | |
| DASGACAAGALPVTG | 6 | Q9NYU2 | |
| RTGNRKASGSACPGS | 76 | Q5FWF6 | |
| PFSIDGLLGGSCAAA | 51 | A6NJT0 | |
| AGAASLSFPGCGRLT | 56 | Q86SH2 | |
| TLPCSGGEGAGAAAT | 316 | Q8WUU4 | |
| PASVSGLAAGSGRDC | 171 | Q8IYS2 |